• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性开角型青光眼患者的药物使用情况:在一家三级护理教学医院进行的前瞻性研究。

Drug use in primary open angle glaucoma: a prospective study at a tertiary care teaching hospital.

机构信息

Department of Pharmacology, Geetanjali Medical College, Udaipur, Rajasthan, India.

出版信息

Indian J Pharmacol. 2013 Mar-Apr;45(2):117-20. doi: 10.4103/0253-7613.108279.

DOI:10.4103/0253-7613.108279
PMID:23716884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3660920/
Abstract

OBJECTIVE

To study drug use pattern in patients of primary open angle glaucoma (POAG) and to analyze the cost of different anti-glaucoma medications.

MATERIALS AND METHODS

This prospective study was carried in the glaucoma clinic of a tertiary care teaching hospital over a period of 9 months. The data collected for patients with POAG included the patient's demographic details and the drugs prescribed. Data were analyzed for drug use pattern and cost drugs used.

RESULTS

In a total 180 prescriptions (297 drugs) analyzed, most drugs (83.83%) were prescribed by topical route as eye drops. β blockers (93.88%) were found to be the most frequently prescribed for POAG. Timolol (82.22%) was the most frequently prescribed drug and timolol with acetazolamide (17.22%) was the most commonly prescribed drug combination. Fixed dose combinations constituted 26.66% of prescriptions. β blockers were found to be cheaper than other anti-glaucoma drugs while prostaglandins analogs were the costliest. Instructions about the route, frequency and duration of treatment were present in all prescriptions. However, instructions regarding instillation of eye drops were missing in all prescriptions.

摘要

目的

研究原发性开角型青光眼(POAG)患者的药物使用模式,并分析不同抗青光眼药物的成本。

材料与方法

本前瞻性研究在一家三级教学医院的青光眼诊所进行,历时 9 个月。POAG 患者的数据包括患者的人口统计学细节和处方的药物。对药物使用模式和使用药物的成本进行了数据分析。

结果

在分析的 180 份处方(297 种药物)中,大多数药物(83.83%)以眼药水的局部途径给药。β受体阻滞剂(93.88%)被发现是最常开的 POAG 药物。噻吗洛尔(82.22%)是最常开的药物,噻吗洛尔与乙酰唑胺(17.22%)是最常开的药物组合。固定剂量组合占处方的 26.66%。β受体阻滞剂比其他抗青光眼药物便宜,而前列腺素类似物则是最贵的。所有处方都有关于治疗途径、频率和持续时间的说明。然而,所有处方都缺少关于滴眼的说明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5c/3660920/dbcc5c8ca8cc/IJPharm-45-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5c/3660920/dbcc5c8ca8cc/IJPharm-45-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5c/3660920/dbcc5c8ca8cc/IJPharm-45-117-g001.jpg

相似文献

1
Drug use in primary open angle glaucoma: a prospective study at a tertiary care teaching hospital.原发性开角型青光眼患者的药物使用情况:在一家三级护理教学医院进行的前瞻性研究。
Indian J Pharmacol. 2013 Mar-Apr;45(2):117-20. doi: 10.4103/0253-7613.108279.
2
Cost analysis of glaucoma medications: a 3-year review.青光眼药物的成本分析:一项为期3年的综述。
J Glaucoma. 2002 Aug;11(4):354-8. doi: 10.1097/00061198-200208000-00013.
3
Medical therapy cost considerations for glaucoma.青光眼的药物治疗成本考量
Am J Ophthalmol. 2003 Jul;136(1):18-25. doi: 10.1016/s0002-9394(03)00102-8.
4
Evaluating eye drop instillation technique in glaucoma patients.评估青光眼患者滴眼剂滴入技术。
J Glaucoma. 2012 Mar;21(3):189-92. doi: 10.1097/IJG.0b013e31820bd2e1.
5
Topical glaucoma therapy cost in Mexico.墨西哥局部青光眼治疗费用。
Int Ophthalmol. 2014 Apr;34(2):241-9. doi: 10.1007/s10792-013-9823-6. Epub 2013 Jul 12.
6
[Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].[原发性开角型青光眼联合治疗中眼脉冲幅度、眼压与β受体阻滞剂/碳酸酐酶抑制作用]
Klin Monbl Augenheilkd. 1999 Dec;215(6):361-6. doi: 10.1055/s-2008-1034733.
7
Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.药物治疗开始后青光眼管理的直接成本。基于德国青光眼治疗观察性研究的模拟模型。
Graefes Arch Clin Exp Ophthalmol. 1998 Nov;236(11):811-21. doi: 10.1007/s004170050165.
8
Prescribing Trends of Topical Glaucoma Medications in Australia From 2001 to 2017.2001 年至 2017 年澳大利亚局部青光眼药物的处方趋势。
J Glaucoma. 2020 Mar;29(3):175-183. doi: 10.1097/IJG.0000000000001414.
9
Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series.原发性开角型青光眼降低眼压最大药物治疗不同组合的比较:12个月回顾性连续病例系列
Jpn J Ophthalmol. 2019 Jul;63(4):322-327. doi: 10.1007/s10384-019-00673-8. Epub 2019 May 21.
10
Persistence with topical glaucoma therapy among newly diagnosed Japanese patients.新诊断日本患者中局部青光眼治疗的坚持情况。
Jpn J Ophthalmol. 2014 Jan;58(1):68-74. doi: 10.1007/s10384-013-0284-2. Epub 2013 Oct 25.

引用本文的文献

1
Understanding the treatment paradigm and the sequencing of antiglaucoma fixed-dose combinations in a tertiary center in South India.了解南印度一家三级中心的抗青光眼固定剂量复方的治疗模式和序贯治疗。
Indian J Ophthalmol. 2024 Jun 1;72(6):896-901. doi: 10.4103/IJO.IJO_694_23. Epub 2024 Apr 16.
2
A Drug Utilization Study of Anti-glaucoma Drugs in a Tertiary Care Hospital.三级护理医院抗青光眼药物的药物利用研究
Cureus. 2023 Oct 9;15(10):e46765. doi: 10.7759/cureus.46765. eCollection 2023 Oct.
3
Evaluation of antiglaucoma drug treatment awareness and patient-reported medication adherence: Determinants of glaucoma management.

本文引用的文献

1
Compliance and adherence in glaucoma management.青光眼管理中的依从性。
Indian J Ophthalmol. 2011 Jan;59 Suppl(Suppl1):S93-6. doi: 10.4103/0301-4738.73693.
2
Medical management of glaucoma: principles and practice.青光眼的医学管理:原则与实践。
Indian J Ophthalmol. 2011 Jan;59 Suppl(Suppl1):S88-92. doi: 10.4103/0301-4738.73691.
3
Natural history of glaucoma.青光眼的自然史。
评价抗青光眼药物治疗意识和患者报告的药物依从性:青光眼管理的决定因素。
J Postgrad Med. 2023 Jul-Sep;69(3):146-152. doi: 10.4103/jpgm.jpgm_905_22.
4
Fixed versus Unfixed Combination of Topical Latanoprost/Timolol for Glaucoma: An Observational Study Investigating the Level of Adherence and Ocular Surface Health.拉坦前列素/噻吗洛尔局部固定复方制剂与非固定复方制剂治疗青光眼的观察性研究:关于依从性水平和眼表健康的调查
J Clin Med. 2023 Apr 26;12(9):3137. doi: 10.3390/jcm12093137.
5
Cost Analysis and Rational Use of Anti-Glaucoma Therapy in a Tertiary Hospital in Ghana.加纳一家三级医院抗青光眼治疗的成本分析与合理使用
Clinicoecon Outcomes Res. 2021 Jul 2;13:619-627. doi: 10.2147/CEOR.S311058. eCollection 2021.
6
Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana-a retrospective cross-sectional study from three referral facilities.加纳原发性开角型青光眼(POAG)的医疗管理成本及处方模式——一项来自三家转诊机构的回顾性横断面研究
BMC Health Serv Res. 2016 Jul 19;16:282. doi: 10.1186/s12913-016-1528-x.
7
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis.原发性开角型青光眼一线药物的比较有效性:一项系统评价和网状Meta分析。
Ophthalmology. 2016 Jan;123(1):129-40. doi: 10.1016/j.ophtha.2015.09.005. Epub 2015 Oct 31.
Indian J Ophthalmol. 2011 Jan;59 Suppl(Suppl1):S19-23. doi: 10.4103/0301-4738.73682.
4
Glaucoma in India: estimated burden of disease.印度的青光眼:疾病负担估计。
J Glaucoma. 2010 Aug;19(6):391-7. doi: 10.1097/IJG.0b013e3181c4ac5b.
5
Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community.日本当地社区近九年来新开具的抗青光眼药物趋势变化
Open Ophthalmol J. 2010 Apr 28;4:7-11. doi: 10.2174/1874364101004010007.
6
Considerations in glaucoma therapy: fixed combinations versus their component medications.青光眼治疗的考量因素:固定复方制剂与其单一成分药物的对比
Clin Ophthalmol. 2010 Feb 2;4:1-9.
7
Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.原发性开角型青光眼的医学管理:与提高患者依从性和持续性相关的最佳实践。
Patient Prefer Adherence. 2008 Feb 2;2:303-14. doi: 10.2147/ppa.s4163.
8
The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.局部青光眼药物滴眼后眼睑闭合和鼻泪管阻塞的重要性,以及在所有患者治疗和临床研究中普遍采用这些技术之一的必要性。
Trans Am Ophthalmol Soc. 2008;106:138-45; discussion 145-8.
9
Practical approach to medical management of glaucoma.青光眼医学管理的实用方法。
Indian J Ophthalmol. 2008 May-Jun;56(3):223-30. doi: 10.4103/0301-4738.40362.
10
First World Glaucoma day, March 6, 2008: tackling glaucoma challenges in India.2008年3月6日首个世界青光眼日:应对印度的青光眼挑战
Indian J Ophthalmol. 2008 Mar-Apr;56(2):97-8. doi: 10.4103/0301-4738.39111.